Eric Juengst, Michael A. Flatt, and Richard A. Settersten, Jr., “Personalized Genomic Medicine and the Rhetoric of Empowerment,”
1552-146X/asset/olbannercenter.jpg?v=1&s=2b0e73835572a7df67119604f32f89972654854c)
article
You have free access to this content
Personalized Genomic Medicine and the Rhetoric of Empowerment
Article first published online: 13 SEP 2012
DOI: 10.1002/hast.65
© 2012 by The Hastings Center
Additional Information
How to Cite
Juengst, E. T., Flatt, M. A. and Settersten, R. A. (2012), Personalized Genomic Medicine and the Rhetoric of Empowerment. Hastings Center Report, 42: 34–40. doi: 10.1002/hast.65
Publication History
- Issue published online: 13 SEP 2012
- Article first published online: 13 SEP 2012
Funded by
- U.S. National Human Genome Research Institute (NHGRI). Grant Number: NIH R01 HG005277
References
- 1, The Structure of Scientific Revolutions, 2nd ed. (Chicago, Ill.: University of Chicago Press, 1970).
- 2, “Genetics and Health Care: A Paradigm Shift,” Perspectives in Biology and Medicine 33 (1990): 203–213 and , “The Human Genome Project and the Future of Medicine,” American Journal of Diseases of Children 147 (1993): 1145–52; Department of Health and Human Services, Personalized Health Care: Pioneers, Partnerships, Progress, November 2008, at 11, http://www.hhs.gov/myhealthcare/news/phc_2008_report.pdf; Personalized Medicine Coalition, “About the Personalized Medicine Coalition (PMC),” http://www.personalizedmedicinecoalition.org/about, accessed December 14, 2011.
- 3, The Language of Life: DNA and the Revolution in Personalized Medicine (New York: Harper Collins, 2010), xxiv–xxv.
- 4, quoted in “The Case for Personalized Medicine,” 3rd ed. (Washington, D.C.: Personalized Medicine Coalition, 2011) at 17, http://www.personalizedmedicinecoalition.org/sites/default/files/files/Case_for_PM_3rd_edition.pdf.
- 5and , “Predictive, Personalized, Preventive, Participatory (P4) Cancer Medicine,” Nature Reviews Clinical Oncology 8, no. 3 (2011): 184–87.
- 6Our analysis is structured using the “social worlds and arenas” theory described in A. Strauss, “A Social World Perspective,” in Studies in Symbolic Interaction, Vol. 1, ed. N. Denzin (Greenwich, Conn.: JAI Press, 1978), 119–28.
- 7
- 8deCODEme, “deCODEme Complete Scan,” https://www.decodeme.com/complete-genetic-scan, accessed August 14, 2009.
- 9, , and , “Personal Genomics and Individual Identities: Motivations and Moral Imperatives of Early Users,” New Genetics and Society 29 (2010): 261–90.
- 10Hood and Friend, “Predictive, Personalized, Preventive, Participatory (P4) Cancer Medicine.”
- 11
- 12Duke Center for Personalized Medicine, “What Is Personalized Medicine?” http://www.dukepersonalizedmedicine.org/what_is_personalized_medicine/, accessed December 14, 2011.
- 13Cleveland Clinic Center for Personalized Healthcare, “About the Center for Personalized Healthcare: Mission and Vision,” http://my.clevelandclinic.org/cph/about-us/mission.aspx, accessed December 14, 2011.
- 14, Medical Sociology, 12th ed. (New York: Prentice Hall, 2011).
- 15, The Great Risk Shift: The Assault on American Jobs, Families, Health Care, and Retirement—and How You Can Fight Back (New York: Oxford University Press, 2006).
- 16Collins, The Language of Life, 278.
- 17Department of Health and Human Services, “Personalized Health Care.”
- 18Personalized Medicine Coalition, “About the Personalized Medicine Coalition.”
- 19, “Emerging Patient-Driven Health Care Models: An Examination of Health Social Networks, Consumer Personalized Medicine, and Quantified Self-Tracking,” International Journal of Environmental Research and Public Health 6 (2009): 492–525.
- 20, “Citizen Empowerment: A Developmental Perspective,” in Studies in Empowerment: Steps towards Understanding and Action, ed. J. Rappaport and R. Hess (New York: Routledge, 1984).
- 21McGowan, Fishman, and Lambrix, “Personal Genomics and Individual Identities.”
- 22et al., “Personal Genomes: Misdirected Precaution,” Nature 456 (2008): 34–35.
- 23, “Genetic Risks and Healthy Choices: Creating Citizen-Consumers of Genetic Services through Empowerment and Facilitation,” Sociology of Health and Illness 32 (2010): 365–81.
- 24University of Utah, “Programmatic Initiatives: Personalized Medicine,” Together We Reach: The Campaign for the University of Utah, http://togetherwereach.net/personalized_medicine.html, accessed December 14, 2011.
- 25, letter to the Food and Drug Administration concerning the Molecular and Clinical Genetics Panel of the Medical Devices Advisory Committee, February 23, 2011, http://www.ama-assn.org/ama1/pub/upload/mm/399/consumer-genetic-testing-letter.pdf.
- 26et al., “Psychopharmacology: Ethnic and Cultural Perspectives,” in Psychiatry, 3rd ed., ed. A. Tasman et al. (Chichester, U.K.: John Wiley and Sons, 2008).
- 27President's Council of Advisors on Science and Technology, “Priorities for Personalized Medicine,” September 2008, http://www.whitehouse.gov/files/documents/ostp/PCAST/pcast_report_v2.pdf.
- 28, , and , “Stratified Medicine: Strategic and Economic Implications of Combining Drugs and Clinical Biomarkers,” Nature Reviews Drug Discovery 6 (2007): 287–93.
- 29Collins, The Language of Life, 163.
- 30Harvey, “Genetics Risks and Healthy Choices.”
- 31, “Is Your DNA Dangerous to Your Health?” Huffington Post, June 18, 2010, http://www.huffingtonpost.com/thomas-goetz/dna-test-is-your-dna-dang_b_616568.html.
- 32and , “The Contractual Genome: How Direct-to-Consumer Genomic Services May Help Patients Take Ownership of Their DNA,” Perspectives in Medicine 5 (2008): 399–404.
- 33, , and , “Impact of Communicating Personalized Genetic Risk Information on Perceived Control over the Risk: A Systematic Review,” Genetics and Medicine 13 (2011): 273–77.
- 34, “Genomic Profiles for Disease Risk: Predictive or Premature?” Journal of the American Medicine Association 299 (2008): 1353–55.
- 35and , “The ‘My-Health’ Revolution: Communication Challenges in the Age of Personalized Medicine,” Journal of Biolaw and Business 10, no. 2 (2007): 23–27, at 25.
- 36and , “The Genomics and Personalized Medicine Act Returns to Congress,” Genomics Law Report, August 24, 2010, http://www.genomicslawreport.com/index.php/2010/08/24/the-genomics-and-personalized-medicine-act-returns-to-congress/.
- 37, “Personalized Medicine: Your 2011 Resolution,” Andrew's Blog, PatientPower.Info, January 3, 2011, http://blog.patientpower.info/2011/01/03/personalized-medicine-your-2011-resolution/.
- 38et al. “After the Revolution? Ethical and Social Challenges in ‘Personalized Genomic Medicine,’” Personalized Medicine 9, no. 4 (2012): 429–39.